 |
 |
 |
|
 |
articles < press << main |
 |
 |
|
|
|
|
|
|
|
| date | | | | title / topic / summary | sort by topic |
|---|
|
| 09/23/2003 | | | | New Spheron Discovery Bolsters Nymox's Alzheimer Therapeutic Pipeline
topic: R&D: Spherons and Alzheimer's Disease
September 23, 2003: Scientists from Nymox Pharmaceutical Corporation announced today that newly discovered molecules represent an important breakthrough in the Company's quest for effective Alzheimer therapeutics. According to Nymox scientists, spherotoxin molecules represent a major new chemical clue about the Alzheimer's disease process. |
| 09/18/2003 | | | | Smoking Cessation Programs Reduce Healthcare Costs for Employers
topic: Tobacco Exposure Tests
September 18, 2003: A new report from the U.S. Department of Health and Human Services (HHS) targets tobacco use - the single most preventable cause of death in the U.S. - as a key part of business strategy to improve productivity and reduce healthcare costs. Nymox's NicAlert™ product is a valuable and cost-effective aid for smoking cessation programs. |
| 09/17/2003 | | | | Nymox Targets AlzheimAlert™ Product for the Global Market
topic: AlzheimAlert™ & Diagnosis of Alzheimer's Disease
September 17, 2003: Nymox Pharmaceutical Corporation is targeting its AlzheimAlert™ product for the global market according to Nymox's Senior Manager for Worldwide Sales and Marketing, Brian Doyle. Nymox recently announced the development of a kit version of its AlzheimAlert™ test that would allow clinical laboratories around the world to perform the test in their own facilities, subject to any necessary regulatory approvals. |
| 09/11/2003 | | | | Nymox Management Announces Up to Four New Investigational Drugs
topic: Financial
September 11, 2003: Nymox Pharmaceutical Corporation announced today that the Company's management anticipates filing up to 4 Investigational New Drug applications (INDs) for new products in the next 12 months. |
| 09/10/2003 | | | | Nymox Reports New Positive Studies of AlzheimAlert™ Product
topic: AlzheimAlert™ & Diagnosis of Alzheimer's Disease
September 10, 2003: Nymox Pharmaceutical Corporation announced today that new studies of its AlzheimAlert™ test product have demonstrated that the product performs extremely well over time. |
| 09/09/2003 | | | | Nymox New TobacAlert™ Product Now Available at CVS Pharmacies
topic: Tobacco Exposure Tests
September 9, 2003: Nymox Pharmaceutical Corporation announced today that its new TobacAlert™ product is now available at selected CVS Pharmacies in the U.S. |
| 09/08/2003 | | | | Nymox Introduces New TobacAlert™ Product
topic: Tobacco Exposure Tests
September 8, 2003: Nymox Pharmaceutical Corporation announced today the commercial launch of TobacAlert™, a new product for non-medical testing of tobacco product exposure. |
| 08/27/2003 | | | | Nymox Announces $12 Million Additional Financing
topic: Financial
August 27, 2003: Nymox Pharmaceutical Corporation announced today that the Company has secured commitment for an additional $12 million in private financing. The funds will be used for general corporate purposes. The private placement of common stock is with institutional investors and is priced at a 3% discount to the market price. |
| 08/26/2003 | | | | New Analyst Report Recommends Nymox Shares
topic: Financial
August 26, 2003: Nymox Pharmaceutical Corporation announced today that J M Dutton & Associates have written a new report recommending Nymox. |
| 08/22/2003 | | | | Recent Surveys Show Nymox Products Widely Featured on Television in U.S. and Abroad
topic: Marketing
August 22, 2003: Nymox Pharmaceutical Corporation products have recently been widely featured in U.S. and European television broadcasts. News of the Company's AlzheimAlert™ and NicAlert™ products and the Company's therapeutic R&D pipeline recently reached a confirmed audience of over 14 million television viewers in the U.S. alone. |
|